NCT01733550

Brief Summary

The purpose of this study is to compare glaucoma patients' own I Care measurements by the standard Goldmann applanation tonometer intraocular pressure (IOP) measurements.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Nov 2012

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 31, 2012

Completed
1 day until next milestone

Study Start

First participant enrolled

November 1, 2012

Completed
26 days until next milestone

First Posted

Study publicly available on registry

November 27, 2012

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2013

Completed
Last Updated

November 28, 2012

Status Verified

September 1, 2012

Enrollment Period

5 months

First QC Date

October 31, 2012

Last Update Submit

November 27, 2012

Conditions

Keywords

Intraocular PressureTonometry, OculariCare

Outcome Measures

Primary Outcomes (1)

  • Intra-ocular pressure with Home ICare and Goldmann Applanation Tonometer.

    Patients eye pressure measurement with both devices. 1. Home ICare measurement by study nurse compared to Home ICare by patient compared to Goldmann ATO by study nurse (once for every patient) 2. 4 times daily: measurement Goldmann ATO (by resident in ophthalmology) and home Icare (by patient)on same moment

    immediate comparison, no time frame required

Secondary Outcomes (1)

  • Patient Comfort

    1 day hospitalisation

Study Arms (1)

Glaucoma patients

Intraocular pressure is measured by Home iCare performed by the study nurse, by the patient it self and by Goldmann applanation tonometry.

Device: Home iCare (study nurse)Device: goldmann applanation tonometryDevice: home iCare (by patient)

Interventions

the intraocular pressure is measured by iCare performed by the study nurse

Glaucoma patients

the intraocular pressure is measured by goldmann applanation tonometry

Glaucoma patients

the intraocular pressure is measured by the iCare performed by the patient him self

Glaucoma patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Glaucoma patients who are admitted to the hospital for repeated eye pressure measurements learn how to handle the home i care during their stay.

You may qualify if:

  • Ocular hypertension (OHT):with/without glaucoma drugs
  • Primary open angle glaucoma (POAG)- high pressure: Diagnosis based on optic nerve head rim loss and/or visual field defects and intraocular pressure (IOP) \>21 mmHg.
  • Primary open angle glaucoma, normal pressure: cfr high pressure but intraocular pressure ≤ 21 mmHg
  • Exfoliative Glaucoma (PEX): Diagnosis based on optic nerve head rim loss and/or visual field defects and intraocular pressure (IOP) \>21 mmHg, with exfoliation material in the anterior segment.
  • Pigmentary Glaucoma (PDG): Diagnosis based on optic nerve head rim loss and/or visual field defects and intraocular pressure (IOP) \>21 mmHg, with Krukenberg's spindle and/or pigment dispersed on the trabecular meshwork.

You may not qualify if:

  • Age \<18 years
  • Other glaucoma types
  • Corneal pathology (edema, dystrophia, corneal transplantation, severe keratoconus, permanent contact lens wear, recurrent corneal erosion)
  • Severe arthritis (unable to handle home i care device)
  • Lack of comprehension
  • Intra ocular surgery and laser treatment during the last 6 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UZLeuven

Leuven, 3000, Belgium

Location

MeSH Terms

Conditions

Glaucoma

Condition Hierarchy (Ancestors)

Ocular HypertensionEye Diseases

Study Officials

  • Ingeborg Stalmans

    Universitaire Ziekenhuizen KU Leuven

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sien Boons, Optometrist

CONTACT

Evelien Dewilde, Resident

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 31, 2012

First Posted

November 27, 2012

Study Start

November 1, 2012

Primary Completion

April 1, 2013

Study Completion

April 1, 2013

Last Updated

November 28, 2012

Record last verified: 2012-09

Locations